Pooja Swamy Innovates R&D with Generative Artificial Intelligence at J&J

Pooja Swamy is leveraging generative Artificial Intelligence for R&D innovation at Johnson & Johnson, driving significant breakthroughs.

Pooja Swamy, just four years into her career after completing her graduate studies, is making waves in the field of research and development at Johnson & Johnson. By utilizing the capabilities of generative Artificial Intelligence, she aims to accelerate innovation and drive significant breakthroughs in the company´s R&D processes. Her journey from academia to applying advanced technologies in a corporate environment demonstrates the transformative potential of Artificial Intelligence in accelerating research outcomes.

Swamy´s work focuses on leveraging generative AI to enhance the efficiency and effectiveness of R&D activities at Johnson & Johnson. By incorporating advanced algorithms, she and her team can simulate numerous scenarios and outcomes that would otherwise take extensive manual calculations and evaluations. This approach not only boosts productivity but also allows researchers to explore a wider scope of possibilities in their projects.

The implementation of generative Artificial Intelligence in R&D is part of a broader trend within the industry where companies are increasingly adopting cutting-edge technologies to stay competitive. Swamy´s contributions highlight the critical role of technology in modernizing research approaches and achieving faster, more accurate results. The emphasis on advanced AI applications reflects Johnson & Johnson´s commitment to innovation and its strategic focus on leveraging new technologies to enhance their product development pipeline.

67

Impact Score

Crescent library brings privacy to digital identity systems

Crescent is a cryptographic library that adds unlinkability to common digital identity formats, preventing tracking across credential uses while preserving selective disclosure. It supports JSON Web Tokens and mobile driver’s licenses without requiring issuers to change their systems.

Artificial Intelligence-powered remote drug testing removes barriers to recovery

Q2i and King’s College London are collaborating to evaluate an Artificial Intelligence-powered at-home drug testing system aimed at people recovering from opioid use disorder. The solution delivers digitally observed, clinically reliable results and pairs testing with contingency management and telehealth to reduce logistical barriers to care.

Contact Us

Got questions? Use the form to contact us.

Contact Form

Clicking next sends a verification code to your email. After verifying, you can enter your message.